Gil Hoftman

Dr. Gil Hoftman is an Assistant Professor in the Department of Psychiatry and Biobehavioral Sciences at the University of California Los Angeles (UCLA) School of Medicine. His research focuses on the intersection of neuroscience and psychiatry, particularly in understanding schizophrenia and psychosis spectrum disorders through neuroimaging, transcriptomic analysis, and neuromodulation techniques such as repetitive transcranial magnetic stimulation (rTMS).

• Institution: University of California Los Angeles
• School: School of Medicine
• Department: Psychiatry and Biobehavioral Sciences
• Academic Rank: Assistant Professor

Dr. Hoftman's work explores the neurobiological substrates of psychiatric conditions, with particular emphasis on:

• 22q11.2 deletion syndrome as a model for psychosis vulnerability
• Transcriptional dysregulation of GABA and glutamate systems in schizophrenia
• Developmental trajectories of cortical circuits
• Optimization of non-invasive brain stimulation protocols
• Integration of multimodal datasets for psychosis research

His recent publications (2023-2025) span topics from neuroimaging signatures of genetic risk for psychosis to clinical trials of rTMS in treatment-resistant depression, with a focus on age and sex-related efficacy differences. Dr. Hoftman collaborates extensively with the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) consortium and contributes to methodological advancements in longitudinal psychiatric research.